Blood Flow Mismatch in Pancreatic Cancers High Point NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

Susan Kidwell Williford, MD
(336) 802-2500
302 Westwood Ave
High Point, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1984

Data Provided by:
George Herbert S Sanders, MD
(336) 802-2500
302 Westwood Ave
High Point, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1988

Data Provided by:
James F Plowden
(336) 802-2500
302 Westwood Ave
High Point, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
James Francis Plowden, MD
(336) 802-2500
302 Westwood Ave
High Point, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Med Univ Of Sc Coll Of Med, Charleston Sc 29425
Graduation Year: 1973
Hospital
Hospital: High Point Regional Hospital, High Point, Nc
Group Practice: Cornerstone Health Care Emerywood

Data Provided by:
Gary Bradley Sherrill, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1989

Data Provided by:
Bart Alan Frizzell, MD
(336) 878-6036
601 N Elm St
High Point, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Tn, Memphis, Coll Of Med, Memphis Tn 38163
Graduation Year: 1996

Data Provided by:
Bernard Ravi Chinnasami, MD
(336) 802-2500
302 Westwood Ave
High Point, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Madras Med Coll, Dr M G R Med Univ, Madras, Tn, India
Graduation Year: 1988

Data Provided by:
Vallathucherry Chakalakumbil Harish
(336) 802-2500
302 Westwood Ave
High Point, NC
Specialty
Hematology / Oncology

Data Provided by:
Dr.Gustav Magrinat
(336) 832-1100
501 North Elam Avenue
Greensboro, NC
Gender
M
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med
Year of Graduation: 1987
Speciality
Oncologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 2, reviews.

Data Provided by:
Peter Robert Ennever
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Hematology, Hematology / Oncology, Medical Oncology

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com